Baxter International | BAX - Loan Capital


Baxter International reported $8.62B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.42M 148.07M Jun/2026
AtriCure USD 61M 0 Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Cooper Companies USD 1.92B 54.8M Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Globus Medical USD 398K 38K Mar/2026
Halozyme Therapeutics USD 1.94B 1.79M Jun/2026
ICU Medical USD 1.21B 49.38M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Medtronic USD 25.62B 502M Jun/2026
Merit Medical Systems USD 736.26M 1.1M Jun/2026
Quest Diagnostics USD 5.63B 477M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026